Serum osteocalcin did not show any response to the onset of osteosarcoma in Paget's disease of bone whereas serum alkaline phosphatase increased rapidly. This suggests that osteocalcin is not useful in the diagnosis and management of Paget's osteosarcoma and does not reflect the same osteoblastic processes in bone as serum alkaline phosphatase.
CASE REPORT
A 65-year-old woman presented in May 1988 with a 10 year history of pain in the right thigh and right knee. The pain prevented her from gardening but not from doing housework. Paget's disease had been diagnosed 5 years previously and treated symptomatically. Examination showed that the right thigh and knees were warm but the circumference of each thigh measured lOcm above the superior border of the patella was the same.
Investigation demonstrated the presence of Paget's disease in the right femur, pelvis, dorsal and lumbar vertebrae and scapula. Serum alkaline phosphatase (SAP), calcium, phosphate, ALT and serum and urine creatinine were measured on a Kodak Ektachem solid phase system (SAP reference range 30-120 u/L, serum ALT up to 50 u/L). Serum osteocalin (SOC) was measured by immunoassay' (reference range for age matched healthy women; 17 f 8 (SD) ng/mL), and urinary hydroxyproline by an automated modification of a method of Bergman and Loxley (reference range for healthy age matched women; up to 120pmol/day). Initial SAP was 733u/L, SOC 95nglmL and urinary hydroxyproline 961 pmol/day. Serum calcium was 2.39 mmol/L, serum phosphate 1.25 mmol/ serum ALT 25u/L and creatinine clearance 73 mL/min.
Treatment was commenced with disodium etidronate (Didronel) 200 mg tds. Four months later she reported that the right knee was less Correspondence: Dr M W J Davie.
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painful and that she had been able to start gardening again. The SAP had not changed from the initial high value but SOC had fallen ( Fig. I) . In December 1988 she complained of severe pain in the right knee which had begun suddenly 3 weeks earlier. The knee and lower thigh were now considerably swollen and X-rays suggested the presence of osteosarcoma at the lower end of the right femur. A W T~M D P scan revealed areas of increased uptake compatible with Paget's disease 
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195 on X-ray. SAP had doubled in 6 weeks whereas SOC continued to fall and urinary hydroxyproline approximated the normal range. Serum ALT and other liver function tests were normal and no secondary deposits in liver or lung were noted on C T scanning. The lower end of the right femur was resected and a knee joint prosthesis inserted (day 299). Following this resection SAP fell to 274u/L but rapidly rose again (Fig. I) . Tumour recurred around the right knee and disarticulation of the right lower limb at the hip joint was necessary on day 398. Osteosarcoma was confirmed histologically in both surgical specimens (Dr Alan Darby, Department of Histopathology, Robert Jones and Agnes Hunt Hospital. Oswestry). Serum calcium remained within the normal range throughout the period of observation.
DISCUSSION
Serum osteocalcin and SAP are both regarded as useful markers of osteoblastic activity, but the SAP/SOC ratio in metabolic bone disease is variable with the ratio being as much as fourfold higher in Paget's disease of bone than in hyperparathyroidism,? and during treatment of Paget's disease with bisphosphonates SAP falls more rapidly than o s t e o c a l~i n .~~~ Unusually in this case osteocalcin fell rapidly during etidronate (Didronel) therapy, paralleling the response of urinary hydroxproline. SAP however initially remained unchanged, later rose briskly and fell with resection of tumour while SOC remained unchanged. The SAP response suggests that removal of tumour load led to a reduction of SAP activity and that recurrence of tumour was associated with a rapid increase of SAP. The normal liver function tests and the normal CT scan of the liver were further evidence that there was no hepatic involvement that might account for the rise of SAP. The disparity between the SAP and SOC values could indicate that osteo-sarcoma cells were expressing only the alkaline phosphatase gene. The differential responses of SAP and SOC indicate that these two measurements reflect different processes within bone. SOC reflects a dynamic balance between production by the osteoblast on the one hand, and a combination of rapid renal excretion and absorption on to bone mineral on the other, whereas the removal of SAP from the circulation occurs over a longer period.
The decline of SOC in the presence of osteosarcoma during treatment of Paget's disease of bone with Didronel suggests that osteocalcin is not valuable in the diagnosis or monitoring of Paget's osteosarcoma.
